fashion -WSS

fashion

author：fashion 2025-09-27 20:38:43 - browse：85455

A purple number 3 with an eye is surrounded by smaller, black number 3s on a green background — 3 to watch coverage from STAT — Christine Kao/STAT

Every winter, like Punxsutawney nobles, biotech’s many thought leaders gather for the J.P. Morgan Healthcare Conference to pick apart the year that was and prognosticate about the one to come. The consensus, in good markets and bad, is almost always cautious optimism for boom times ahead, a prediction that in recent years has had groundhog-level accuracy.

But after two years of steady decline, 2024 might finally prove them right. Biotech is on the upswing, driven by the rise of some headline-grabbing medicines, the advance of cutting-edge technologies, and a few reminders that big drug companies are still willing to pay billions of dollars for small ones.

Here are three major themes that we expect to drive the news in 2024 and determine whether biotech’s comeback is a sustainable trend or an interest-rate phenomenon.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Apple is now the first public company to be valued at $3 trillion
Next article： Humana CEO Bruce Broussard to step down in 2024

Wikipedia

WSS

Readout Newsletter: Amylyx, Alto Neuro, and Eli Lilly for the Oscars

European regulators recommend Amylyx's ALS drug be rejected

Wellcome Trust names Røttingen as its new CEO

STAT Readout: Today's biotech news includes Sana and Amylyx

Change Healthcare payments predicted restored March 15

Nick Jonas talks about managing diabetes along with his career

focus

fashion

hotspot

Cancer drug shortages should be causing more outrage

A revolution in caring for preterm infants

FDA approval of Sarepta Duchenne genetic therapy gives me hope

The drug industry has found itself all alone in Washington

Tori Bowie and the unacceptable rates of Black maternal death

How clinical AI models' predictive power can degrade over time

Medical leaders decry Supreme Court decision on affirmative action

Cancer cells are shown to suck energy source from immune cells

Bright Health sells Medicare Advantage business to Molina

IVF, abortion rights issues kick off Biden’s State of the Union

focus

Kidney disease boosts cardiac arrest risk for Hispanics, Latinos

Life sciences deals on track to hit lowest point since 2017

Nick Jonas talks about managing diabetes along with his career

Bernie Sanders bashes nonprofit hospitals over their tax breaks

Researchers CRISPR chickens in bid to protect them from bird flu

Medicare to cover more brain scans related to Alzheimer’s drugs

hotspot

Wikipedia

focus

hotspot